Wednesday, April 3, 2019

FDA-approved drug effectively treats rare chronic immune disorder

Small NIH clinical trial conducted in partnership with AstraZeneca.

From https://www.nih.gov/news-events/news-releases/fda-approved-drug-effectively-treats-rare-chronic-immune-disorder



from
https://healthnews010.wordpress.com/2019/04/04/fda-approved-drug-effectively-treats-rare-chronic-immune-disorder/

No comments:

Post a Comment